Will valuations mar Cipla-Serum walk down the aisle?

Will India's Cipla and Serum Institute progress their current alliance for vaccines into a potential combination?

Will India's Cipla and Serum Institute progress their current alliance for vaccines into a potential combination?

That's a tough question, at least for now, say a clutch of investment bankers. They point to potential valuation roadblocks...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category